[Previous Months][Date Index][Thread Index][Join - Register][Login]   Help@Insulin-Pumpers.org
  [Message Prev][Message Next][Thread Prev][Thread Next]   for subscribe/unsubscribe assistance

[IPu] FW: [IP] RE: aspirin / High aspirin dosage may curb heart attack risk in diabetes

Hi All,
The research, plus some further thoughts about it's interpretation ..

-----Original Message-----
From: email @ redacted
[mailto:email @ redacted] On Behalf Of Ricardo
Sent: Saturday, 9 July 2011 1:37 AM
To: email @ redacted
Subject: [IP] RE: aspirin / High aspirin dosage may curb heart attack risk
in diabetes

John Wrote:
 High aspirin dosage may curb heart attack risk in diabetes Increasing
dosage may help curb heart attack risk in patients with diabetes, according
researchers at the University of Alberta in Canada. A researcher said those
had daily doses of up to 325 milligrams of aspirin had 23% reductions in
cardiovascular-related mortality.

What do we do?

Ricardo Responds:
Hi John,

 Not to discredit the results, but I would use some caution in interpreting
results of this study.

 This study did not actually run a controlled study that compared high dose
aspirin vs. low dose vs. no aspirin subjects. The study is a meta-analysis
studies done over the last 30 or so years and so it is simply a statistical
analysis of data.

 A criticism of meta analysis is the lack of control for bias and
Were the high dose aspirin users more health conscious and therefore less
susceptible to CHD? Did they smoke less than the control group? How did
body weight compare to a control group? What other medications did the high
subjects take? In addition, the conclusion seems to violate the basic
principle that "correlation does not necessarily imply causation". Saying
those who took high dose aspirin had less CHD mortality, therefore high dose
aspirin decreases CHD mortality is no more proof of theory than saying that
roosters crow before the sun rises, therefore roosters cause the sun to

 It is also well known that CHD mortality has in general decreased over the
year time span of this study, yet CHD morbidity has increased. This study
addresses a decrease in mortality, with no mention of morbidity. So the
agrees with a general trend that was already in place, so the best we may be
able to say is that high dose aspirin is a contributing factor to decreasing
risk of dying from CHD, but not preventing CHD, which I am assuming is the
ultimate goal for most diabetics.

 The anti-inflammatory, blood thinning effects of aspirin are well known,
long term high dose usage can have side effects in some people. Google can
you to some more natural alternatives.

More on the study can be seen here:

for HELP or to subscribe/unsubscribe, contact: HELP@insulin-pumpers.org
help SUPPORT Insulin Pumpers http://www.insulin-pumpers.org/donate.shtml